BioInvent and Transgene Announce Compelling Preclinical Data for BT-001 in Solid Tumors

11. Dezember 2019 INDIZES WEUR

LUND, Sweden and STRASBOURG, France, Dec. 11, 2019 /PRNewswire/ — BioInvent International AB (publ) (OMXS: BINV), a biotech company focused on the discovery and development of novel and …
(Orginal – Story lesen…)

Tags: atx cac ftse ibex omxs wig-20

You may also like...